×
Entrez Id:
1499
Gene Symbol:
CTNNB1
CTNNB1
0.400
Biomarker
disease
BEFREE
γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.
23555187
2013
×
Entrez Id:
1499
Gene Symbol:
CTNNB1
CTNNB1
0.400
Biomarker
disease
BEFREE
β2 spectrin-mediated differentiation repressed the properties of liver cancer stem cells through β-catenin .
29555987
2018
×
Entrez Id:
3091
Gene Symbol:
HIF1A
HIF1A
0.300
Therapeutic
disease
RGD
[Prevention of hepatic tumor growth and metastasis in rats with rapamycin].
19335982
2009
×
Entrez Id:
7010
Gene Symbol:
TEK
TEK
0.200
Biomarker
disease
RGD
[Expression of Ang2 and Tie2 and their relation with the angiogenesis of hepatocellular carcinoma in rats].
16951510
2006
×
Entrez Id:
2354
Gene Symbol:
FOSB
FOSB
0.310
Biomarker
disease
CTD_human
[Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].
26411935
2015
×
Entrez Id:
406928
Gene Symbol:
MIR137
MIR137
0.020
Biomarker
disease
BEFREE
[Corrigendum] MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2.
29568886
2018
×
Entrez Id:
4087
Gene Symbol:
SMAD2
SMAD2
0.220
Biomarker
disease
RGD
[Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis].
18971187
2008
×
Entrez Id:
4089
Gene Symbol:
SMAD4
SMAD4
0.200
Biomarker
disease
RGD
[Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis].
18971187
2008
×
Entrez Id:
574460
Gene Symbol:
MIR498
MIR498
0.010
Biomarker
disease
BEFREE
ZEB2 overexpression rescued the inhibition of liver cancer cell proliferation, migration, and invasion by miR‑498 , indicating that ZEB2 acts as a downstream effector of miR‑498 in liver cancer cells.
30592286
2019
×
Entrez Id:
9221
Gene Symbol:
NOLC1
NOLC1
0.010
Biomarker
disease
BEFREE
Yet, the functioning of NOLC1 in liver cancer remains unknown.
23970161
2013
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
0.590
Biomarker
disease
BEFREE
Yet Bmi1 functions independent of Ink4A /Arf repression in liver cancer development.
19934271
2009
×
Entrez Id:
407053
Gene Symbol:
MIR96
MIR96
0.200
ModifyingMutation
disease
RGD
Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
25813403
2015
×
Entrez Id:
1499
Gene Symbol:
CTNNB1
CTNNB1
0.400
Biomarker
disease
BEFREE
Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis.
28671671
2017
×
Entrez Id:
1499
Gene Symbol:
CTNNB1
CTNNB1
0.400
Biomarker
disease
BEFREE
Wnt/beta-catenin activation is observed in normal liver development, regeneration, and liver cancer .
16012954
2005
×
Entrez Id:
8644
Gene Symbol:
AKR1C3
AKR1C3
0.020
AlteredExpression
disease
BEFREE
Withdrawal: "A novel AKR1C3 specific prodrug TH3424 with potent anti-tumor activity in liver cancer " Ping He, Chunnian Wang, Yanlan Wang, Caiyan Wang, Changhua Zhou, Donglin Cao, Jiang Li, David A. Bushnell, Qing Li, Roger D. Kornberg, Wei Xie, Zhong Wang.
31654399
2019
×
Entrez Id:
174
Gene Symbol:
AFP
AFP
0.100
Biomarker
disease
BEFREE
With this approach, an aptamer specific to alpha-fetoprotein (AFP ), which is a biomarker for liver cancers , has been successfully selected.
22410487
2012
LGALS3BP
0.020
Biomarker
disease
BEFREE
Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment.
28537900
2017
LGALS3BP
0.020
Biomarker
disease
BEFREE
Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
27973711
2017
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
0.590
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016
×
Entrez Id:
7015
Gene Symbol:
TERT
TERT
0.560
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016
×
Entrez Id:
324
Gene Symbol:
APC
APC
0.510
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016
×
Entrez Id:
595
Gene Symbol:
CCND1
CCND1
0.390
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016
×
Entrez Id:
378938
Gene Symbol:
MALAT1
MALAT1
0.370
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016
×
Entrez Id:
283131
Gene Symbol:
NEAT1
NEAT1
0.320
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016
×
Entrez Id:
55870
Gene Symbol:
ASH1L
ASH1L
0.300
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016